Filing Details
- Accession Number:
- 0001209191-13-044434
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-16 20:19:49
- Reporting Period:
- 2013-09-13
- Filing Date:
- 2013-09-16
- Accepted Time:
- 2013-09-16 20:19:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1319874 | M Joseph Feczko | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-09-13 | 10,000 | $6.03 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $5.995 to $6.08 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.